JPMorgan Chase & Co. Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price

Key Points

• JPMorgan cut its price target on Tempus AI from $85 to $80 and kept a neutral rating, with the new target implying roughly a 14.3% upside from the prior close.
• Analysts are evenly split—seven Buys, seven Holds and one Sell—resulting in a consensus Hold rating and an average price target of $85.36.
• Tempus posted strong revenue growth (up 84.7% year-over-year) and beat last quarter's estimates but remains unprofitable (negative margins and PE), while insiders have sold about 1.10 million shares (~$86M) in the past 90 days.

Tempus AI (NASDAQ:TEM - Get Free Report) had its price target reduced by investment analysts at JPMorgan Chase & Co. from $85.00 to $80.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price target indicates a potential upside of 14.33% from the stock's previous close.

Other research analysts have also recently issued research reports about the stock. TD Cowen cut shares of Tempus AI from a "buy" rating to a "hold" rating and set a $88.00 price target on the stock. in a research note on Tuesday, October 21st. Guggenheim raised their target price on Tempus AI from $80.00 to $95.00 and gave the stock a "buy" rating in a report on Friday, September 26th. Canaccord Genuity Group cut their price target on Tempus AI from $110.00 to $95.00 and set a "buy" rating for the company in a report on Wednesday, November 5th. BTIG Research upped their price target on Tempus AI from $96.00 to $105.00 and gave the stock a "buy" rating in a research report on Tuesday, November 25th. Finally, Cowen cut Tempus AI from a "buy" rating to a "hold" rating in a research report on Tuesday, October 21st. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Tempus AI currently has a consensus rating of "Hold" and a consensus price target of $85.36.

Tempus AI Trading Down 0.9%

TEM traded down $0.64 on Monday, hitting $69.97. 2,032,223 shares of the company were exchanged, compared to its average volume of 10,719,602. Tempus AI has a 12 month low of $31.36 and a 12 month high of $104.32. The stock has a market capitalization of $12.45 billion, a PE ratio of -58.80 and a beta of 5.00. The firm has a fifty day simple moving average of $80.97 and a two-hundred day simple moving average of $73.59. The company has a debt-to-equity ratio of 2.45, a quick ratio of 3.12 and a current ratio of 3.28.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, beating analysts' consensus estimates of ($0.16) by $0.05. The business had revenue of $334.21 million during the quarter, compared to analyst estimates of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. Tempus AI's revenue was up 84.7% compared to the same quarter last year. During the same period last year, the business earned ($0.46) EPS. Sell-side analysts expect that Tempus AI will post -6.15 earnings per share for the current year.

Insider Buying and Selling

In other Tempus AI news, EVP Andrew Polovin sold 12,874 shares of the firm's stock in a transaction on Monday, November 24th. The stock was sold at an average price of $75.00, for a total value of $965,550.00. Following the transaction, the executive vice president owned 107,590 shares in the company, valued at approximately $8,069,250. This trade represents a 10.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Ryan Fukushima sold 10,099 shares of Tempus AI stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $65.54, for a total transaction of $661,888.46. Following the completion of the transaction, the chief operating officer owned 829,081 shares of the company's stock, valued at $54,337,968.74. This trade represents a 1.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,097,780 shares of company stock worth $86,054,406 over the last ninety days. 26.27% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Tempus AI

Several institutional investors have recently modified their holdings of TEM. Cranbrook Wealth Management LLC acquired a new position in Tempus AI during the 3rd quarter worth $25,000. Concord Wealth Partners increased its stake in shares of Tempus AI by 308.0% during the second quarter. Concord Wealth Partners now owns 408 shares of the company's stock worth $26,000 after buying an additional 308 shares during the period. JPL Wealth Management LLC purchased a new stake in shares of Tempus AI during the 3rd quarter worth approximately $26,000. GAMMA Investing LLC acquired a new position in Tempus AI during the third quarter worth $28,000. Finally, Allworth Financial LP increased its position in Tempus AI by 5,000.0% during the second quarter. Allworth Financial LP now owns 459 shares of the company's stock worth $29,000 after buying an additional 450 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.